For example, bevacizumab, which is a VEGF inhibitor that has shown improved PFS and quality of life in glioblastoma patients, prevents angiogenesis within the vasculature compartment without the need of being present inside the tumor cells [10,11,12]. Here, VEGFA is linked to glioblastoma.